Alteplase: Double bolus versus accelerated regimen

Medical Science Monitor

Volumn 8, Issue 10, 2002, Pages

  Ruiz Bailén, Manuel ^a   De Hoyos, Eduardo Aguayo ^a   Hurtado Ruiz, Benjamín ^a   Reina Toral, Antonio ^a   Díaz Castellanos, Miguel Ángel ^a   Issa Khozouz, Ziad ^a   Martinez Coronel J F ^a   Barrero Acedo, F ^a   Mayor Garcia D M ^a   Cordoba Escanez J ^a   Ramos Cuadra, J A ^a   Fierro Roson J L ^a   Cardenas Cruz A ^a   Sanchez Rodriguez A ^a   Ramos Fernandez de Canete P ^a   Rodriguez Yanez J C ^a   Dios Torronteras, F ^a   Guerrero Arjona, A ^a   Reina Toral, A ^a   Barranco, F ^a   Mercado Martinez J M ^a   Rucabado Aguilar, L ^a   Carrillo Garrido, A ^a   De Molina Ortega, A ^a   Bartolome Sanz A ^a   Ferriz Martin J ^a   Garcia Paredes T ^a   Garcia Alcantara A ^a   Varela Lipez A ^a   Mateo Sanchez J I ^a   Garcia Garcia A ^a   Arboleda Sanchez A ^a   Maza Rodriguez B ^a   Rios Ortiz F ^a   Canabal Berlanga, A ^a   Perez Llorens J C ^a   Rodriguez Alonso M ^a   Lopez Onega P ^a   Monton A ^a   Ayuela, J M ^a   Cancelo Suarez P ^a   Alvarez, B ^a   Lopez Mesa J ^a   Ancillo Garcia P ^a   Cortina Gomez J J ^a   Medina Santaolaya, P ^a   Sanz Hernan J J ^a   Muriel Bombin A ^a   Armentia, J ^a   Miguel Servet, J ^a   Garcia Lavajo ^a   De la Fuente, F ^a   Del Nogal Sáez, Frutos ^a   Gomez Tello V ^a   Sanchez Martos A ^a   Sánchez, A Jaime ^a   Felices Abad, F ^a   Segura Cuenca, J ^a   Mira, E ^a   Gomez Ramos M J ^a   Melgarejo, A ^a   Gil, F J ^a   Lozano, J I ^a   Nicolas, S ^a   Rodriguez J ^a   Carrillo, A ^a   Canovas Robles J ^a   Guardiola Navarro, F ^a   Roche, A ^a   Cardona, J ^a   Martin J A ^a   Rodriguez J A ^a   Criado, F ^a   Ortega Moya, J ^a   Segura, V ^a   Garcia M ^a   Cunat J ^a   Roig, M ^a   Lopez Puerta J J ^a   Calvo, R ^a   Simo, M ^a   more..

^a HOSPITAL DE PONIENTE   (Spain)

Author keywords

Acute myocardial infarction; Complications; Mortality; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; AORTA BALLOON; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; CORONARY STENT; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION; HEMODYNAMIC MONITORING; HEMORRHAGIC SHOCK; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; REVASCULARIZATION; TREATMENT OUTCOME; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; MORTALITY;

AGED; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 1842867147     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The GUSTO investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med, 1993; 329: 673-682
2. Neuhaus KI, Feuer W. Jeep-Tebbe S et al: Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol, 1989; 14: 1566-1569
3. Neuhaus KI, von Essen R, Tebbe U et al: Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study. J Am Coll Cardiol, 1992; 19: 885-891
4. Clozel JP, Tschopp T, Luedin E, Holvoet P: Time course of thrombolysis induced by intravenous bolus or infusion of tissue plasminogen activator in a rabbit jugular vein thrombosis model. Circulation, 1989; 79: 125-133
5. Agnelli G, Buchanan MR, Fernández F et al: Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits. Blood, 1985; 66: 399-401
6. Andreotti F, Cluft C, Hackett DR et al: Thrombin generation after fast or prolonged regimens of tissue-type plasminogen activator. Lancet, 1993; 342: 937-938
7. Tebbe U, Tanswell P, Seifried E et al: Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol, 1989; 64: 448-453
8. Purvis JA, Trouton TG, Roberts MJ et al: Effectiveness of double bolus alteplase in the treatment of acute myocardial infarction. Am J Cardiol, 1991; 68: 1570-1574
9. Genmmill JD, Hogg KJ, Maclntyre PD et al: A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction. Br Heart J, 1991; 66: 134-138
10. Purvis JA, Mc Neill AJ, Siddiqui RA et al: Ellicacy of 100 mg of double bolus alteplase in achieving complete perfusion in the treatment of acute myocardial in farction. J AM Coll Cardiol, 1994; 23: 6-10
11. The continuous infusion versus double-bolus administration of alteplase (COBALT) investigators: A comparison of continuous infusion of alteplase with doulbe-bolus administration for acute myocardial infarction. N Engl J Med, 1997; 337: 1124-1130
12. Ware JH. Antman E: Equivalence Trials. N Engl J Med, 1997; 337: 1159-1161
13. Brophy J Thrombolytic Therapy for Myocardial Infarction. N Engl J Med, 1998; 338: 545-546
14. Andreotti F: Thrombolytic Therapy for Myocardial Infarction. N Engl J Med, 1998; 338: 546-547
15. Bleich SD, Adgey AAJ, McMechan SR, Love TW: DouBLE Study Investigators. An angiographic assessment of alteplase: Double-bolus and front-loaded infusion regimens in myocardial infarction. Am Heart J, 1998; 136: 741-748
16. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators: A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med, 1997; 337: 1118-1123
17. Álvarez Bueno M, Vera Almazán A, Rodríguez Garcia JJ et al: Concept, development and objectives of project ARIAM. Med Intensiva, 1999; 23: 273-280
18. Aguayo de Hoyos E, Reina Toral A, Colmenero Ruiz M et al: Analysis of delays in the treatment of acute coronary syndrome. Data in the Registry ARIAM. Med Intensiva, 1999; 23: 280-287
19. Reina Toral A, Aguayo de Hoyos E, Colmenero Ruiz M et al: Mortality in acute myocardial infarction. Med Intensiva, 1999; 23: 288-293
20. González Díaz F, Gnerrero Gómez FJ, Martínez Coronel J F et al: Fibrinolytic agents in the project ARIAM. Exclusion reasons and complications. Med Intensiva, 1999; 23: 294-300
21. Killip T III, Kimball JT: Treatment of myocardial infarction in a coronary care unit: A two year experience with 250 patients. Am J Cardiol, 1967; 20: 457-464
22. Chesebro JH, Knatterud G, Roberts R et al: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase 1: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation, 1987; 76: 142-154
23. Carney RJ, Murphy GA, Brandt TR et al: Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase in myocardial infarction. RAMMI Study Investigators. J Am Coll Cardiol, 1992; 20: 17-23
24. The GUSTO Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med, 1993; 329: 1615-1622
25. Bode C, Smalling RW, Berg G et al: Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Circulation, 1996; 94: 891-898
26. Gibson CM, Cannon CP, Daley WI. et al: TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation, 1996; 93: 879-888
27. Birnbaum Y, Wagner GS, Barbash GI et al: Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarction. Am J Cardiol, 1999; 83: 143-148
28. Sobel BE, Nachiowak DA, Fry ETA et al: Paradoxical attenuation of fibrinolysis attributable to 'plasminogen steal' and its implications for coronary thrombolysis. Coron Artery Dis, 1990; 1: 111-119
29. Torr Sr, Nachiowak DA, Fujii S, Sobel BE: 'Plasminogen steal' and clot lysis. J Am Coll Cardiol, 1992; 19: 1085-1090
30. Mehta SR, Eikelboom JW, Yusuf S: Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: A meta-analysis. Lancet, 2000; 356: 449-454